These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 15630726)

  • 21. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
    Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H
    J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
    Lung; 2009; 187(3):201-6. PubMed ID: 19387736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic infections in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Hellot MF; Herson S; Levesque H; Hatron PY
    Arthritis Rheum; 2005 Apr; 53(2):155-65. PubMed ID: 15818648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
    Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW
    Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M; Hara M; Kamatani N; Kashiwazaki S
    Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
    Li Q; Lu BX; Zhou L; An SL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematological malignancy associated with polymyositis and dermatomyositis.
    Marie I; Guillevin L; Menard JF; Hatron PY; Cherin P; Amoura Z; Cacoub P; Bachelez H; Buzyn A; Le Roux G; Ziza JM; Brice P; Munck JN; Sarrot-Reynauld F; Piette JC; Larroche C
    Autoimmun Rev; 2012 Jul; 11(9):615-20. PubMed ID: 22079677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)].
    Saeki T; Suzuki E; Watanabe T; Saito Y; Itou S; Honma T; Sato T; Nakano M; Arakawa M
    Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy].
    Li R; Li XP; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Zhang H
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2335-8. PubMed ID: 23158563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.
    Mochimaru H; Kawamoto M; Enomoto T; Saitoh Y; Abe S; Nei T; Fukuda Y; Kudoh S
    Respirology; 2008 Nov; 13(6):863-70. PubMed ID: 18811885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease.
    Takada T; Suzuki E; Nakano M; Kagamu H; Tsukada H; Hasegawa T; Satoh M; Haraguchi M; Ebe T; Arakawa M
    Intern Med; 1998 Aug; 37(8):669-73. PubMed ID: 9745852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-pathological manifestations in interstitial lung diseases associated with polymyositis-dermatomyositis].
    Shi JH; Xu WB; Liu HR; Tian XL; Feng RE; Xu ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):250-4. PubMed ID: 18846959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
    Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
    Saku N; Ohno S; Sugiyama Y; Kitamura S
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
    Sugiyama Y; Yoshimi R; Tamura M; Takeno M; Kunishita Y; Kishimoto D; Yoshioka Y; Kobayashi K; Takase-Minegishi K; Watanabe T; Hamada N; Nagai H; Tsuchida N; Soejima Y; Nakano H; Kamiyama R; Uehara T; Kirino Y; Sekiguchi A; Ihata A; Ohno S; Nagaoka S; Nakajima H
    Arthritis Res Ther; 2018 Jan; 20(1):7. PubMed ID: 29325580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.